open access

Vol 83, No 6 (2012)
ARTICLES
Get Citation

Smooth muscle tumor of uncertain malignant potential (STUMP) – clinico-pathomorphological analysis of the cases and literature review

Anna Dańska-Bidzińska, Elwira Bakuła-Zalewska, Anna Nasierowska-Guttmejer, Magdalena Kowalewska, Edyta Barnaś, Piotr Sobiczewski, Mariusz Bidziński
Ginekol Pol 2012;83(6).

open access

Vol 83, No 6 (2012)
ARTICLES

Abstract

Objectives: This retrospective study was designed to evaluate the clinical and pathological features and outcomes of patients diagnosed with uterine smooth muscle tumor of uncertain malignant potential (STUMP). Material and methods: Ten patients diagnosed with uterine STUMP and seen between 2008 and 2011 at the Memorial Cancer Center – Institute of Oncology in Warsaw were identified using the institution databases. Variables of interest included histopathological details, age at diagnosis, types of treatment and recurrence rate. Results: The mean age at diagnosis was 41 years (range 25–56 years). The mean follow-up time was 16 months (range 4–29 months). Diameter of the tumors ranged from 3 to 29 cm. Uterine bleeding was the second most frequent symptom observed in this cohort. In three cases conservative procedure was performed, whereas in other patients hysterectomy was performed. No recurrence was observed during the follow-up period. In all tumors mitoses were less than 10 per 10/hpf, atypia of middle or severe type, and in 3 cases necrosis was observed. In half of the tumors expression of TP53 was found, and value of MIB 1 was estimated at 2-35%. Conclusions: STUMP should be diagnosed by experienced pathologists due to the fact that they are often misdiagnosed as leiomyosarcomas. Clinical behavior of these tumors allows to consider a conservative management in patients wishing to preserve fertility.

Abstract

Objectives: This retrospective study was designed to evaluate the clinical and pathological features and outcomes of patients diagnosed with uterine smooth muscle tumor of uncertain malignant potential (STUMP). Material and methods: Ten patients diagnosed with uterine STUMP and seen between 2008 and 2011 at the Memorial Cancer Center – Institute of Oncology in Warsaw were identified using the institution databases. Variables of interest included histopathological details, age at diagnosis, types of treatment and recurrence rate. Results: The mean age at diagnosis was 41 years (range 25–56 years). The mean follow-up time was 16 months (range 4–29 months). Diameter of the tumors ranged from 3 to 29 cm. Uterine bleeding was the second most frequent symptom observed in this cohort. In three cases conservative procedure was performed, whereas in other patients hysterectomy was performed. No recurrence was observed during the follow-up period. In all tumors mitoses were less than 10 per 10/hpf, atypia of middle or severe type, and in 3 cases necrosis was observed. In half of the tumors expression of TP53 was found, and value of MIB 1 was estimated at 2-35%. Conclusions: STUMP should be diagnosed by experienced pathologists due to the fact that they are often misdiagnosed as leiomyosarcomas. Clinical behavior of these tumors allows to consider a conservative management in patients wishing to preserve fertility.
Get Citation

Keywords

smooth muscle tumors, histopathology, diagnosis, treatment

About this article
Title

Smooth muscle tumor of uncertain malignant potential (STUMP) – clinico-pathomorphological analysis of the cases and literature review

Journal

Ginekologia Polska

Issue

Vol 83, No 6 (2012)

Bibliographic record

Ginekol Pol 2012;83(6).

Keywords

smooth muscle tumors
histopathology
diagnosis
treatment

Authors

Anna Dańska-Bidzińska
Elwira Bakuła-Zalewska
Anna Nasierowska-Guttmejer
Magdalena Kowalewska
Edyta Barnaś
Piotr Sobiczewski
Mariusz Bidziński

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl